Thyroid hormones levels in patients with schizophrenia receiving conventional and atypical antipsychotics

被引：0
|
作者：
Tiguntsev, V. [1 ]
Mednova, I. [1 ]
Lobacheva, O. [2 ]
Kornetova, E. [3 ]
机构：
[1] Mental Hlth Res Inst, Lab Mol Genet & Biochem, Tomsk, Russia
[2] Mental Hlth Res Inst, Lab Clin Psychoneuroimmunol & Neurobiol, Tomsk, Russia
[3] Mental Hlth Res Inst, Dept Endogenous Disorders, Tomsk, Russia
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2021年 / 53卷
关键词：
D O I：
10.1016/j.euroneuro.2021.10.566
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.0601
引用
收藏
页码：S441 / S441
页数：1
相关论文
共 50 条
  • [41] Changes in glucose, lipid levels, and body weight in Korean patients with schizophrenia treated with atypical antipsychotics
    Kim, CE
    Lee, MH
    Bae, JN
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 564 - 565
  • [42] Correlation between plasma homovanillic acid levels and the response to atypical antipsychotics in male patients with schizophrenia
    Kaneda, Y
    Kawamura, I
    Ohmori, T
    CLINICAL NEUROPHARMACOLOGY, 2005, 28 (06) : 262 - 264
  • [43] Insight in persons with schizophrenia - Effects of switching from conventional neuroleptics to atypical antipsychotics
    Aguglia, E
    De Vanna, M
    Onor, ML
    Ferrara, D
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2002, 26 (7-8): : 1229 - 1233
  • [44] Placebo-controlled trial of lamotrigine added to conventional and atypical antipsychotics in schizophrenia
    Kremer, I
    Vass, A
    Gorelik, I
    Bar, G
    Blanaru, M
    Javitt, DC
    Heresco-Levy, U
    BIOLOGICAL PSYCHIATRY, 2004, 56 (06) : 441 - 446
  • [45] Patient satisfaction after switching from conventional to new atypical antipsychotics in schizophrenia
    Bartkó, G
    Váradi, H
    Simon, L
    Linka, E
    Tüske, T
    Szabó, T
    Sántha, J
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2002, 6 (01) : 9 - 14
  • [46] Switching conventional antipsychotics to risperidone in stable patients with schizophrenia
    Nakanishi, S
    Kunugi, H
    Takahashi, T
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2005, 20 (03) : A6 - A7
  • [47] Positive encenicline exposure-response relationships for cognition and clinical function in schizophrenia patients receiving atypical antipsychotics
    Loewen, G.
    Kuan, H.
    Dgetluck, N.
    Hilt, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S471 - S472
  • [48] Stereotypy in schizophrenic patients on atypical antipsychotics versus conventional neuroleptics
    Morrens, M.
    Hulstijn, W.
    Sabbe, B. G. C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S392 - S393
  • [49] Neurological soft signs and neuroleptics in schizophrenia. A retrospective comparative study in patients treated with conventional and atypical antipsychotics
    Gherardelli, S
    Clemente, R
    Bersani, G
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S418 - S419
  • [50] Predictors of medication adherence among schizophrenia patients treated with conventional and atypical antipsychotics in a large state medicaid program
    Lee, S. P.
    Lang, K.
    Jackel, J.
    Crivera, C.
    Dirani, R. G.
    Menzin, J.
    VALUE IN HEALTH, 2008, 11 (03) : A123 - A123
12345